Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gang Bian
Institution:
Antengene Corporation Limited (China)
Observed institutions:
Soochow University,
Antengene Corporation Limited (China)
ORCID:
0009-0008-1154-8764
Observed ORCID:
0009-0008-1154-8764
OpenAlex ID:
A5058255461
Anti-H1N1 viral activity of three main active ingredients from zedoary oil
2020
·
Ling Li
, Qing Xie
, et al.
·
Fitoterapia
·
29
Glycosphingolipid GM3 is Indispensable for Dengue Virus Genome Replication
2016
·
Kezhen Wang
, Juanjuan Wang
, et al.
·
International Journal of Biological Sciences
·
26
PDF
Molecular characterization of a defensin gene from a hard tick, Dermacentor silvarum
2015
·
Juanjuan Wang
, Gang Bian
, et al.
·
Parasites & Vectors
·
26
PDF
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
·
Cancer Research
·
21
DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation
2020
·
Gang Bian
, Lidan Wang
, et al.
·
British Journal of Pharmacology
·
15
Effects of Different Doses of Nucleocapsid Protein from Hantaan Virus A9 Strain on Regulation of Interferon Signaling
2015
·
Wen Pan
, Gang Bian
, et al.
·
Viral Immunology
·
11
Data from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Data from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Table S6 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Data from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Table S4 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Table S3 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Table S4 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Supplementary Table S5 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
2024
·
Hui Yuwen
, Huajing Wang
, et al.
Show more works
View as search
Works count:
14
Citation count:
128
H-index:
6
I10-index:
6
Year
Topic
Type
